首页|孟鲁司特用于治疗感染后咳嗽的疗效分析

孟鲁司特用于治疗感染后咳嗽的疗效分析

扫码查看
目的 讨论孟鲁司特用于治疗感染后咳嗽的临床效果.方法 选取2016年1月~2017年2月台州医院门诊诊治的感染后咳嗽患者100例作为研究对象,随机分为实验组50例和对照组50例,对照组给予天一止咳糖浆,实验组在对照组的基础上给予孟鲁司特钠,对2组患者的治疗效果、咳嗽积分进行对比和分析.结果 实验组患者的临床有效率为96.0%,明显高于对照组的70.0%,组间差异具有统计学意义(P<0.05);实验组患者治疗后的咳嗽积分明显优于对照组,组间差异具有统计学意义(P<0.05).结论 孟鲁司特在治疗感染后咳嗽的临床效果明确,并且安全性较高.
Efficacy of montelukast for the treatment of cough after infection
Objective To discuss the clinical effect of montelukast in the treatment of cough after infection. Methods 100 cases of patients with cough after infection in Taizhou hospital from January 2016 to February 2017 were randomly divided into the experimental group and the control group, 50 cases for each group, the control group was given oral Tianyi Zhike tangjiang liquid, the experimental group was given montelukast sodium on the basis of the control group, the treatment effect and cough integral between two groups after infection were compared and analyzed. Results The clinical effective rate of the experimental group was 96.0%, significantly higher than the control group 70.0%, the differences between groups was statistically significant (P<0.05). Cough scores in the experimental group after the treatment were significantly better than the control groupwith statistical significance (P<0.05). Conclusion Montelukast in the treatment of cough after infectious has clear clinical effect, and high safety.

montelukastcoughinfectioneffect

顾倩倩

展开 >

台州医院 呼吸内科,浙江 临海 317000

孟鲁司特 咳嗽 感染 效果

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(10)
  • 4
  • 9